(Q37074253)

English

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

scientific article published on 30 January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease (English)

1 reference

Europe PubMed Central

18 August 2017

author name string

J J Scarisbrick

1

1 reference

Europe PubMed Central

18 August 2017

P Taylor

2

1 reference

Europe PubMed Central

18 August 2017

U Holtick

3

1 reference

Europe PubMed Central

18 August 2017

Y Makar

4

1 reference

Europe PubMed Central

18 August 2017

K Douglas

5

1 reference

Europe PubMed Central

18 August 2017

G Berlin

6

1 reference

Europe PubMed Central

18 August 2017

E Juvonen

7

1 reference

Europe PubMed Central

18 August 2017

S Marshall

8

1 reference

Europe PubMed Central

18 August 2017

Photopheresis Expert Group

9

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

30 January 2008

1 reference

Europe PubMed Central

18 August 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

18 August 2017

158

1 reference

Europe PubMed Central

18 August 2017

4

1 reference

Europe PubMed Central

18 August 2017

659-678

1 reference

Europe PubMed Central

18 August 2017

Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Photopheresis: clinical applications and mechanism of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus-host disease: observations in four patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Chronic graft-versus-host disease: where do we go from here?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

How I treat chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy--the Columbia Presbyterian experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis of cutaneous T-cell lymphoma is associated with reduction of peripheral CD4+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Prognosis, clinical outcomes and quality of life issues in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Photopheresis therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Circulating CD4+CD7− Lymphocyte Burden and Rapidity of Response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photochemotherapy (ECP) in treatment of patients with c-GVHD and CTCL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08415.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2007.08415.X

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37074253&oldid=1682169631"